NCT03170336View on ClinicalTrials.gov

A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Amiloride

Amiloride first for 8 weeks, then for a washout for 4 weeks, and cross over to receive hydrochlorothiazide for another 8 weeks.

DRUG

Hydrochlorothiazide

hydrochlorothiazide first for 8 weeks, then for a washout for 4 weeks, and cross over to receive amiloride for another 8 weeks.

Trial Locations (1)

Unknown

Nephrology Dept,Guangdong General Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT03170336 - A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein | Biotech Hunter | Biotech Hunter